StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) stock

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Karyopharm Therapeutics's enterprise value was -$64.19M on Nov 9, 2026, against $3.01M a year earlier. Over the last 5 years it ranged from -$137.29M to $546.86M, with a median of -$17.92M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 9, 2026-$64.19M-453.7%
2025Dec 31, 2025$18.15M–
2024Dec 31, 2024-$48.76M–
2023Dec 29, 2023-$108.68M-185.5%
2022Dec 30, 2022$127.11M-54.8%
2021Dec 31, 2021$281.27M-67.9%
2020Dec 31, 2020$875.17M-6.4%
2019Dec 31, 2019$934.53M+158.4%
2018Dec 31, 2018$361.66M+8.5%
2017Dec 29, 2017$333.27M+35.2%
2016Dec 30, 2016$246.59M-11.3%
2015Dec 31, 2015$277.95M-72.0%
2014Dec 31, 2014$993.63M+15268.1%
2013Dec 31, 2013$6.47M–

More Karyopharm Therapeutics figures

See a number that looks wrong?